Realistic expectations and a disease management model for depressed patients with persistent symptoms

被引:49
作者
Keitner, Gabor I. [1 ]
Ryan, Christine E. [1 ]
Solomon, David A. [1 ]
机构
[1] Brown Univ, Sch Med, Providence, RI 02912 USA
关键词
D O I
10.4088/JCP.v67n0912
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Objective: To describe the efficacy of currently available treatments for depression in achieving remission and to highlight additional strategies for those patients who continue to experience persistent depressive symptoms in spite of optimal treatment. Data Sources: The authors reviewed the literature (electronic and hand searches) on the efficacy of current pharmacologic and psychotherapeutic antidepressant treatments and the utility of a chronic disease management model. A search of PubMed was conducted for English-language articles published from 1980 to 2005 using the keywords depression treatments, outcome, course of illness, and treatment resistant depression. Data Synthesis: Current treatments for depression leave a significant minority (20%-40%) of patients with persistent depressive symptoms. A disease management model that may be useful for major depressive disorder is described. Conclusions: The goal of treating depression to achieve remission, although ideal, is currently unattainable for many patients. The long-term care of patients with persisting depressive symptoms may be well served by adding a disease management component to the overall treatment strategy. Doing so may help to improve coping, interpersonal functioning, and quality of life.
引用
收藏
页码:1412 / 1421
页数:10
相关论文
共 138 条
  • [1] *AG HLTH CAR PUBL, 1993, AHCPR PUBL, V93
  • [2] Effectiveness of disease management programs in depression: A systematic review
    Badamgarav, E
    Weingarten, SR
    Henning, JM
    Knight, K
    Hasselblad, V
    Gano, A
    Ofman, JJ
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (12) : 2080 - 2090
  • [3] Tolerance in antidepressant treatment
    Baldessarini, RJ
    Ghaemi, SN
    Viguera, AC
    [J]. PSYCHOTHERAPY AND PSYCHOSOMATICS, 2002, 71 (04) : 177 - 179
  • [4] Barbee JG, 2004, J CLIN PSYCHIAT, V65, P975
  • [5] Amitriptyline v. the rest:: still the leading antidepressant after 40 years of randomised controlled trials
    Barbui, C
    Hotopf, M
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2001, 178 : 129 - 144
  • [6] BECK AT, 1985, ARCH GEN PSYCHIAT, V42, P142
  • [7] THE EFFICACY OF COGNITIVE THERAPY IN DEPRESSION - A TREATMENT TRIAL USING COGNITIVE THERAPY AND PHARMACOTHERAPY, EACH ALONE AND IN COMBINATION
    BLACKBURN, IM
    BISHOP, S
    GLEN, AIM
    WHALLEY, LJ
    CHRISTIE, JE
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1981, 139 (SEP) : 181 - 189
  • [8] Patient self-management of chronic disease in primary care
    Bodenheimer, T
    Lorig, K
    Holman, H
    Grumbach, K
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (19): : 2469 - 2475
  • [9] Boyer W, 2001, TREATMENT-RESISTANT MOOD DISORDERS, P159, DOI 10.1017/CBO9780511666421.009
  • [10] A 25-year longitudinal, comparison study of the outcome of depression
    Brodaty, H
    Luscombe, G
    Peisah, C
    Anstey, K
    Andrews, G
    [J]. PSYCHOLOGICAL MEDICINE, 2001, 31 (08) : 1347 - 1359